Skip to main navigation Skip to search Skip to main content

PROMise: Investigation into the combination of a Plexxikon BETi with ruxolitinib in patients with high or intermediate-2 risk myelofibrosis not recieving an adequate respnse with ruxolitinib alone (Adam Mead)

Project Details

Short titlePROMise: Investigation into the combination of a Plexxikon BETi with ruxolitinib in patients with high or intermediate-2 risk myelofibrosis not recieving an adequate respnse with ruxolitinib alone (Adam Mead)
StatusActive
Effective start/end date1/05/19 → 31/12/27

Funding

  • PLEXXIKON INC
  • Cancer Research UK
  • Opna-IO LLC